APN1125

· CoMentis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for APN1125, covering 2016-04-08 to 2016-07-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia [Phase 1, Phase 2]